Title |
Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system
|
---|---|
Published in |
Patient preference and adherence, October 2008
|
DOI | 10.2147/ppa.s3464 |
Pubmed ID | |
Authors |
Chandra Kailasam, David Cahill |
Abstract |
The levonorgestrel-containing intrauterine system is an extremely effective, reversible and safe form of long-term yet reversible birth control. In view of its efficacy, it is a safer alternative to permanent contraceptive methods such as sterilization. It is especially useful in situations where use of estrogen-containing contraceptives is contraindicated. While menstrual disturbances are a common side effect, proper counseling improves compliance. In addition to its contraceptive effect, the levonorgestrel intrauterine system offers potential therapeutic benefits in other clinical contexts, including menorrhagia, symptomatic fibroids, endometriosis, and endometrial protection. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Indonesia | 1 | 1% |
United Kingdom | 1 | 1% |
Unknown | 83 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 25 | 29% |
Student > Master | 11 | 13% |
Student > Postgraduate | 8 | 9% |
Student > Ph. D. Student | 7 | 8% |
Researcher | 4 | 5% |
Other | 9 | 11% |
Unknown | 21 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 34 | 40% |
Nursing and Health Professions | 5 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 6% |
Biochemistry, Genetics and Molecular Biology | 4 | 5% |
Agricultural and Biological Sciences | 3 | 4% |
Other | 11 | 13% |
Unknown | 23 | 27% |